We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Accelerating Progress in Preventing Resistance to Anticancer Drugs

News   Aug 05, 2020 | Original story from the Huntsman Cancer Institute

 
Accelerating Progress in Preventing Resistance to Anticancer Drugs

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports. Credit: Huntsman Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

Anti-Alzheimer's Gene Variant Enhances Immune Cells

News

A new study conducted by researchers at the University of Eastern Finland found that a genetic variant named PLCG2-P522R, which protects against Alzheimer's disease, enhances several key functions of immune cells.

READ MORE

New Drug Could Offer Hope for Muscular Dystrophy Patients

News

A new drug offers hope for young boys with the progressive neuromuscular disease Duchenne muscular dystrophy (DMD) by potentially offering an alternative to high-dose glucocorticoids that have significant side effects.

READ MORE

Team Identifies Potential Drug Target for Severe E. coli Infections

News

UNSW Science researchers have studied an E. coli strain responsible for a severe intestinal infection in humans, enterohemorrhagic E. coli (EHEC). They have discovered a new molecular pathway that controls Shiga toxin production, this finding is important because there is no commercially available treatment for EHEC infections currently.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE